Clinical Trial Update: Longitudinal Observational Study of Severe Asthma

View source ↗

Summary

The NHLBI-sponsored longitudinal observational study on severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Asthma | Status: COMPLETED